The legacy of Viagra and its originator, copyright, presents a tangled picture for cautious investors. While the blockbuster drug initially fueled enormous profits , its patent has expired , leading to generic versions flooding the landscape . This reduction in pricing presents a significant hurdle for copyright and any portfolio considering a heav